To access this element change to forms mode OFF
Grant Award View - GA171691
Safer medicines To reduce falls and fractures for OsteoPorosis (#STOP)
GA ID:
GA171691
Agency:
Department of Health and Aged Care
Approval Date:
20-May-2021
Publish Date:
15-Jun-2021
Category:
Medical Research
Grant Term:
11-Jun-2021 to 6-Dec-2025
Value (AUD):
$2,337,170.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 20/21 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Safer medicines To reduce falls and fractures for OsteoPorosis (#STOP)
Purpose:
The project will evaluate a coordinated and integrated referral pathway for a pharmacist–led medication review for consumers with osteoporosis that have sustained a minimal trauma fracture. This intervention aims to decrease falls risk and refracture by reducing the use of medicines that lead to falls and improve the use of anti–osteoporosis medicines for bone strength. Individuals will be identified via Osteoporosis Refracture Prevention (ORP) services at 7 clinical sites across NSW and Victoria. The recommendations of the pharmacists' review will be shared with the ORP specialists, the consumers' primary care providers and a lay summary will be shared with the consumer to empower them to discuss their shared–care plan with their GP and pharmacist.
GO ID:
GO Title:
MRFF 2020 Quality, Safety and Effectiveness of Medicine Use and Medicine Intervention by Pharmacists Grant Opportunity
Internal Reference ID:
MRFQI000064
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
UNIVERSITY OF SYDNEY
Recipient ABN:
15 211 513 464
Grant Recipient Location
Suburb:
CAMPERDOWN
Town/City:
The University of Sydney
Postcode:
2006
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
2006
Country:
AUSTRALIA